| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1998PNAS...9510158Z |
| P356 | DOI | 10.1073/PNAS.95.17.10158 |
| P932 | PMC publication ID | 21478 |
| P698 | PubMed publication ID | 9707617 |
| P5875 | ResearchGate publication ID | 13576930 |
| P2093 | author name string | D Wang | |
| P D Fan | |||
| Y W Kan | |||
| L Zhang | |||
| H Fischer | |||
| J H Widdicombe | |||
| J Y Dong | |||
| P2860 | cites work | Identification of the cystic fibrosis gene: chromosome walking and jumping | Q22299423 |
| Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA | Q28119124 | ||
| Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. | Q34732912 | ||
| Cystic fibrosis transmembrane conductance regulator: a chloride channel with novel regulation | Q35318538 | ||
| Cystic fibrosis: molecular biology and therapeutic implications | Q35319385 | ||
| Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. | Q35871002 | ||
| Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector | Q35872651 | ||
| Chloride channel and chloride conductance regulator domains of CFTR, the cystic fibrosis transmembrane conductance regulator | Q35935185 | ||
| Abnormal regulation of ion channels in cystic fibrosis epithelia | Q36586832 | ||
| Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector | Q36663364 | ||
| Epithelial cell dysfunction in cystic fibrosis: implications for airways disease | Q38790982 | ||
| The actin filament disrupter cytochalasin D activates the recombinant cystic fibrosis transmembrane conductance regulator Cl- channel in mouse 3T3 fibroblasts | Q41258928 | ||
| Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA. | Q41485634 | ||
| Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter | Q41573620 | ||
| Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer | Q41721279 | ||
| Expression and characterization of the cystic fibrosis transmembrane conductance regulator. | Q41838750 | ||
| Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. | Q42483788 | ||
| Effect of deletion mutations on the function of CFTR chloride channels | Q42674559 | ||
| A method for measuring Cl efflux from dispersed cells of airway epithelium | Q42829729 | ||
| CFTR gene transduction in neonatal rabbits using an adeno-associated virus (AAV) vector | Q45279254 | ||
| Recombinant adeno-associated virus for muscle directed gene therapy | Q45764433 | ||
| Quantitative analysis of the packaging capacity of recombinant adeno-associated virus | Q45766162 | ||
| Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. | Q45866166 | ||
| Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: a phase I trial | Q45866236 | ||
| Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. | Q45866338 | ||
| Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung | Q45867192 | ||
| Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates. | Q45878651 | ||
| Adenovirus-mediated generation of cAMP-stimulated Cl- transport in cystic fibrosis airway epithelia in vitro: effect of promoter and administration method | Q45881877 | ||
| Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV. | Q45952048 | ||
| Fluid transport across cultures of human tracheal glands is altered in cystic fibrosis | Q46064004 | ||
| Cyclic AMP-dependent protein kinase opens chloride channels in normal but not cystic fibrosis airway epithelium | Q58113448 | ||
| Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells | Q59073603 | ||
| Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine | Q64382406 | ||
| Effect of Deleting the R Domain on CFTR-Generated Chloride Channels | Q67694895 | ||
| Altered regulation of airway epithelial cell chloride channels in cystic fibrosis | Q68967044 | ||
| Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle | Q73254110 | ||
| Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus | Q77292224 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vector-borne disease | Q2083837 |
| P304 | page(s) | 10158-10163 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Efficient expression of CFTR function with adeno-associated virus vectors that carry shortened CFTR genes | |
| P478 | volume | 95 |
| Q33902133 | A PDZ-interacting domain in CFTR is an apical membrane polarization signal |
| Q48347827 | A combined analysis of the cystic fibrosis transmembrane conductance regulator: implications for structure and disease models |
| Q28256353 | A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner |
| Q37393822 | A novel chimeric adenoassociated virus 2/human bocavirus 1 parvovirus vector efficiently transduces human airway epithelia. |
| Q33864423 | A shortened adeno-associated virus expression cassette for CFTR gene transfer to cystic fibrosis airway epithelia. |
| Q33840994 | AAV vectors: is clinical success on the horizon? |
| Q35012413 | Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. |
| Q34016471 | CFTR with a partially deleted R domain corrects the cystic fibrosis chloride transport defect in human airway epithelia in vitro and in mouse nasal mucosa in vivo |
| Q92258204 | CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities |
| Q35043830 | Current status of gene therapy for inherited lung diseases |
| Q58595420 | Cystic Fibrosis Gene Therapy: Looking Back, Looking Forward |
| Q34582621 | Cystic fibrosis transmembrane conductance regulator with a shortened R domain rescues the intestinal phenotype of CFTR-/- mice. |
| Q33664918 | Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies |
| Q45162912 | Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway. |
| Q34762614 | Effects of C-terminal deletions on cystic fibrosis transmembrane conductance regulator function in cystic fibrosis airway epithelia |
| Q51712353 | Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. |
| Q40532563 | Engagement of the B-cell antigen receptor (BCR) allows efficient transduction of ZAP-70-positive primary B-CLL cells by recombinant adeno-associated virus (rAAV) vectors |
| Q45865993 | Expression of a truncated cystic fibrosis transmembrane conductance regulator with an AAV5-pseudotyped vector in primates |
| Q35200182 | Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy |
| Q39877658 | Functional cystic fibrosis transmembrane conductance regulator expression in cystic fibrosis airway epithelial cells by AAV6.2-mediated segmental trans-splicing |
| Q36925241 | Gene therapy for the treatment of cystic fibrosis |
| Q33482133 | Generation of novel AAV variants by directed evolution for improved CFTR delivery to human ciliated airway epithelium |
| Q34447817 | Hot topics in adeno-associated virus as a gene transfer vector |
| Q40207332 | Human Bocavirus Type-1 Capsid Facilitates the Transduction of Ferret Airways by Adeno-Associated Virus Genomes |
| Q40850802 | Localization of sequences within the C-terminal domain of the cystic fibrosis transmembrane conductance regulator which impact maturation and stability |
| Q36012920 | Novel molecular approaches to cystic fibrosis gene therapy |
| Q35821858 | Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers |
| Q24533013 | Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps |
| Q42425977 | Protein trans-splicing as a means for viral vector-mediated in vivo gene therapy |
| Q35111738 | Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. |
| Q40816480 | Regulatory interaction between the cystic fibrosis transmembrane conductance regulator and HCO3- salvage mechanisms in model systems and the mouse pancreatic duct |
| Q40906944 | Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing |
| Q24791598 | The PEST sequence does not contribute to the stability of the cystic fibrosis transmembrane conductance regulator |
| Q90075755 | Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease |
Search more.